Skip to main content
Vitercure
Medically reviewed by Dr. Jane Rote, MD Direct Oral Anticoagulant (DOAC)
Rx Only Eliquis apixaban tablets blister packs and box Oral anticoagulant

ARISTOTLE Trial, Apixaban vs Warfarin

21%

fewer strokes

31%

less major bleeding

11%

lower mortality

ARISTOTLE trial: apixaban vs warfarin in nonvalvular AFib (N=18,201). Individual results vary.

Eliquis at a Glance

  • Direct oral anticoagulant (factor Xa inhibitor).
  • Reduces stroke risk in nonvalvular atrial fibrillation.
  • Treats and prevents DVT and pulmonary embolism.
  • No routine INR monitoring required (unlike warfarin).
  • Taken twice daily, with or without food.

Direct Oral Anticoagulant (DOAC)

Buy Eliquis® (Apixaban) Online

Stroke and clot prevention, 2.5mg and 5mg tablets

ARISTOTLE trial: 21% fewer strokes and 31% less major bleeding vs warfarin

Eliquis is a direct factor Xa inhibitor that helps prevent blood clots from forming. It is used to reduce stroke risk in patients with nonvalvular atrial fibrillation and to treat or prevent blood clots in the legs (DVT) and lungs (PE). Unlike warfarin, Eliquis does not require routine INR blood monitoring or frequent dose adjustments, and has fewer dietary restrictions.

A Vitercure clinician reviews your diagnosis, kidney function, bleeding history, medications, and procedural plans before determining if Eliquis is appropriate and which dose to use.

Managed anticoagulation therapy

Select your strength and source below. One-time packs, no auto-subscriptions.

Source: United States, 2.5mg and 5mg Tablets

Eliquis tablets from licensed US partner pharmacies.

$389.00

One-time cost. Telehealth visit billed separately.

Source: Canada, 2.5mg and 5mg Tablets

Eliquis tablets from licensed Canadian partner pharmacies.

$369.00

One-time cost. Telehealth visit billed separately.

Source: United Kingdom, 2.5mg and 5mg Tablets

Eliquis tablets from licensed UK partner pharmacies.

$349.00

One-time cost. Telehealth visit billed separately.

Number of packs:

HIPAA-compliant, 256-bit encrypted. A valid prescription is required.

Licensed US, Canada, and UK pharmacies HIPAA-secure telehealth Discreet, trackable shipping

What Is Eliquis (Apixaban)?

Eliquis is a direct factor Xa inhibitor, part of the class of medications called direct oral anticoagulants (DOACs). It works by blocking factor Xa, a key protein in the blood clotting cascade, which helps prevent dangerous clots from forming. It is used to reduce stroke risk in patients with nonvalvular atrial fibrillation, to treat blood clots in the legs (DVT) and lungs (PE), and to prevent clots after hip or knee replacement surgery.

ARISTOTLE Trial: Eliquis vs Warfarin

The ARISTOTLE trial (18,201 patients with nonvalvular AFib) compared apixaban 5mg twice daily against warfarin. Apixaban reduced the risk of stroke or systemic embolism by 21%, reduced major bleeding by 31%, and reduced all-cause mortality by 11% compared to warfarin. These results established Eliquis as a preferred alternative to warfarin for many AFib patients.

Eliquis Drug Facts

Generic nameApixaban
ClassDirect factor Xa inhibitor (DOAC)
Strengths2.5mg and 5mg oral tablets
UsesStroke prevention in nonvalvular AFib; DVT/PE treatment and prevention; prophylaxis after hip or knee replacement
MonitoringKidney function, liver function, and bleeding risk reviewed periodically by your clinician

How to Use Eliquis

  • Form: Oral tablet (2.5mg or 5mg).
  • Frequency: Usually twice daily, as prescribed.
  • With food: May be taken with or without food.
  • Missed dose: Take as soon as you remember on the same day, then resume your regular schedule the next day. Do not double the dose.
  • Important: Never stop Eliquis on your own without medical advice. Your risk of stroke or blood clots may increase. Discuss any upcoming surgeries, dental work, or procedures with your clinician.
Dose selection: The dose (2.5mg or 5mg twice daily) depends on your specific condition, age, weight, kidney function, and other medications. Your Vitercure clinician will determine the correct dose after reviewing your full profile. Do not adjust your dose without their guidance.

Important Safety Information for Eliquis

This is not a complete list. Always review the full Prescribing Information and speak with a licensed clinician.

Do Not Use If:

  • You have active pathological bleeding.
  • You have known hypersensitivity to apixaban or any component.
  • Your clinician has determined anticoagulants are not appropriate for your condition.

Bleeding Risk

Eliquis increases the risk of bleeding, which can sometimes be serious or life-threatening. Seek urgent care for prolonged nosebleeds, unusual bruising, black or bloody stools, pink or brown urine, coughing or vomiting blood, or sudden severe headaches.

Common Side Effects

Easy bruising, minor nosebleeds, or mild gum bleeding can occur. Let your clinician know if these become frequent or bothersome. Serious bleeding requires emergency medical attention.

Frequently Asked Questions About Eliquis

Eliquis (apixaban) is a direct oral anticoagulant used to reduce the risk of stroke and systemic embolism in certain patients with nonvalvular atrial fibrillation. It is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), and for prevention after hip or knee replacement surgery.

Eliquis does not require routine INR blood monitoring or frequent dose adjustments like warfarin does. In the ARISTOTLE trial, apixaban reduced stroke risk by 21% and major bleeding by 31% compared to warfarin in patients with atrial fibrillation. It also has fewer dietary restrictions.

Eliquis is typically taken twice daily, with or without food. The dose (2.5mg or 5mg) depends on your specific condition, age, weight, and kidney function. Your clinician will determine the correct dose for you.

Take the missed dose as soon as you remember on the same day, then resume your regular schedule the next day. Do not double the dose. If you are unsure, contact your clinician. Never stop Eliquis without medical advice, as your clot or stroke risk may increase.

Yes. Through Vitercure, a licensed clinician reviews your medical history, bleeding risk, kidney function, and current medications through our HIPAA-compliant telehealth platform. If appropriate, they can prescribe Eliquis from licensed US, Canadian, or UK pharmacy partners.

The most important risk is bleeding, which can sometimes be serious. Common signs include easy bruising, minor nosebleeds, or gum bleeding. Seek emergency care for severe or uncontrollable bleeding, black or bloody stools, pink or brown urine, coughing blood, or sudden severe headaches.

Eliquis vs Warfarin: Why Patients Are Switching

For decades, warfarin was the only oral anticoagulant available. It works well but requires frequent blood tests (INR monitoring), careful dietary management (vitamin K intake affects dosing), and frequent dose adjustments. Eliquis changed this landscape. In the ARISTOTLE trial, apixaban reduced stroke risk by 21% and major bleeding by 31% compared to warfarin, while also being easier to manage in daily life. Most patients on Eliquis do not need routine INR monitoring, have fewer dietary restrictions, and experience more predictable anticoagulation.

That said, Eliquis is not appropriate for everyone. Patients with mechanical heart valves still require warfarin. Patients with severe kidney impairment may need dose adjustments or alternative therapy. And warfarin has the advantage of a well-established reversal agent (vitamin K) compared to Eliquis (andexanet alfa, which is newer and not available everywhere). Your Vitercure clinician will evaluate which anticoagulant is right for your specific situation.

Dr. Jane Rote, MD

Medically Reviewed

This content was reviewed for clinical accuracy by Dr. Jane Rote, MD, board-certified in endocrinology and metabolism. Last reviewed: November 2025.

This information is educational and does not substitute for professional medical advice.

Need a Managed Anticoagulation Plan?

Start with a short questionnaire. A licensed clinician reviews your history and determines whether Eliquis or another anticoagulant is appropriate, then helps you understand dosing, duration, and follow-up.